India Diagnostic Imaging Devices Market Size and Forecast by Modality, Application, Technology, End User, and Portability: 2019-2033

---

Empowering Diagnostics Through Public-Private Synergy and Health Inclusion

The growth of India diagnostic imaging devices industry is driven by large public health initiatives and private healthcare expansion. The rollout of Ayushman Bharat Health Infrastructure Mission (PM-ABHIM) is establishing integrated district hospitals equipped with MRI, CT, and PET modalities. Meanwhile, private hospital chains such as Apollo, Fortis, and Max Healthcare are expanding tertiary care centers equipped with advanced CT and MRI systems to meet rising oncology and cardiovascular imaging demand.

India’s growing status as a global medical tourism hub, with more than 650,000 inbound medical travelers annually, has also strengthened demand for high-end imaging technologies. Local imaging startups are partnering with global OEMs to offer modular, low-maintenance diagnostic systems. Furthermore, the Department of Pharmaceuticals has supported domestic medical device parks, helping reduce dependence on imports for components of X-ray and MRI systems. These efforts collectively enhance self-reliance while improving the country’s diagnostic resilience.

Barriers in the Path of Progress: Affordability and Policy Complexity

Despite the strong momentum, several constraints challenge the full realization of India’s diagnostic imaging potential. Price sensitivity remains a major concern, particularly in Tier-2 and rural regions. Hospitals and imaging centers are often constrained by limited capital budgets, favoring refurbished or shared imaging units. Furthermore, complex import duties and fragmented state-level procurement frameworks delay adoption of next-generation devices, especially for public sector hospitals.

The lack of standardized maintenance protocols and a shortage of certified radiologic technologists also hinder efficiency. Additionally, regulatory pathways for AI-assisted diagnostics remain under development by the Central Drugs Standard Control Organization (CDSCO), creating uncertainty for innovators in image analytics and tele-imaging technologies. Overcoming these constraints requires harmonization of procurement policies and stronger public-private cooperation in workforce training and device certification.

Emerging Technological Shifts Reshaping India Diagnostic Imaging Devices Sector

The India diagnostic imaging devices market is undergoing a structural transformation marked by rapid adoption of portable and connected imaging solutions. Portable ultrasound devices are witnessing strong uptake among obstetric and point-of-care clinicians due to improved affordability and reliability. The growing penetration of teleradiology platforms is extending diagnostic services to remote geographies, enabling real-time consultation and second opinions across states.

Domestic manufacturing and assembly of imaging systems are rising as part of the government’s “Make in India” initiative. Localization reduces costs, mitigates import duties, and strengthens supply chain autonomy. Furthermore, major global players are leveraging India as a design and R&D hub for affordable, emerging-market models of CT and MRI systems. Integration of AI-based analytics for oncology and neurology imaging is improving early detection outcomes and reducing scan interpretation times.

Seizing the Next Wave: Opportunities in Affordable Imaging and Teleradiology Partnerships

India diagnostic imaging devices ecosystem presents strong opportunities for companies offering localized mid-tier MRI and CT systems designed for smaller hospitals and diagnostic chains. With the growing demand for refurbished imaging equipment certified by the Bureau of Indian Standards (BIS), players can cater to cost-conscious providers while maintaining quality assurance.

Teleradiology partnerships are gaining prominence as hospitals collaborate with specialized networks for image reading and analysis. Building national teleradiology grids integrated with the ABDM framework can help bridge diagnostic gaps in low-resource districts. Additionally, scalable AI-driven imaging models, focused on tuberculosis, breast cancer, and cardiovascular screening, represent a high-impact opportunity aligned with national health priorities.

Competitive Landscape: Innovation and Localization Defining Market Leadership

The competitive landscape of India diagnostic imaging devices sector is intensifying as both multinational corporations and domestic firms localize production. Global leaders such as GE HealthCare India, Philips India, and Healthcare continue to introduce advanced imaging solutions tailored for local conditions. In August 2025, Samsung launched its next-generation mobile CT portfolio in India, integrating AI-assisted image reconstruction to enhance diagnostic accuracy in rural zones. Similarly, Indian startup OneMRI raised USD 25 million in August 2025 to expand affordable full-body MRI services across metro and semi-urban centers, cutting scan costs by up to 80%.

Indian manufacturers like Trivitron Healthcare and Allengers are increasingly focusing on localized assembly and technology partnerships to enhance cost competitiveness. The industry is expected to witness a strong wave of mergers, OEM collaborations, and digital integrations as hospitals and imaging centers seek interoperable and AI-ready equipment. As India’s healthcare infrastructure modernizes, the ability to deliver high-quality imaging at scale will remain the defining competitive differentiator.